Clinical trial
POS vs FLU for First Line Treatment of Coccidioidomycosis (Study…
NCT00423267 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00423267 |
|---|---|
| Title | POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED) |
| Official title | A Multicenter, Randomized, Controlled, Double-Blind, Double-Dummy, Two-Arm Study of Posaconazole vs Fluconazole in the Treatment of Coccidioidomycosis |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coccidioidomycosis |
| Intervention type | Drug |
| Interventions | Posaconazole, Fluconazole |
| Enrollment | 16 |
| Start date | May 1, 2007 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Jan 18, 2007 |
| Last update posted | Apr 11, 2017 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: